Status:
COMPLETED
Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients
Lead Sponsor:
Instituto Materno Infantil Prof. Fernando Figueira
Collaborating Sponsors:
Bellisa Caldas Lopes
Thuanne Beatriz Silva Tenório
Conditions:
Infection, Catheter-Related
Central Line-associated Bloodstream Infection (CLABSI)
Eligibility:
All Genders
Up to 5 years
Phase:
PHASE3
Brief Summary
Central venous catheter (CVC) infection is a common complication in pediatric patients, resulting in prolonged length of stay in hospital, requiring antibiotics, invasive procedures and increase morbi...
Detailed Description
The patients was divided into two groups, where one received alcoholization (ethanol lock therapy group) and the other not (control group). The variables evaluated were: CLABSI, etiological agents, ad...
Eligibility Criteria
Inclusion
- Pediatric surgery patients;
- Weight: 2 Kg or more;
- Using non-tunneled double-lumen polyurethane central venous catheter;
- CVC inserted at operation room, Pediatric Intensive Care Unit (PICU) or Neonatal Intensive Care Unit (NICU);
- CVC adequately positioned (checked by radioscopy ou radiography);
- CVC implanted within a maximum of 24 hours.
Exclusion
- Patients whose catheters had been inserted under emergency situations;
- Patients in a critical condition (those requiring continuous fluid/drug infusion through both lumens);
- Patients with a history of hypersensitivity or allergic reactions to ethanol were excluded from the study.
Key Trial Info
Start Date :
March 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2017
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03253887
Start Date
March 1 2016
End Date
April 1 2017
Last Update
November 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto de Medicina Integral Prof Fernando Figueira
Recife, Pernambuco, Brazil, 50070-550